- Home
- / Grand Pharmaceutical Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Grand Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.7
2024-10-29
Market Capitalization
$16 B
2024-10-29
Revenue
$12.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jul 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| HKD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.0B | 6.6B | 6.4B | 8.6B | 9.6B | 10.5B | 11.6B | 12.3B |
| Cost of goods sold | 2.4B | 1.9B | 1.8B | 2.7B | 2.7B | 3.0B | 3.8B | 4.4B |
| Gross profit | 3.7B | 4.9B | 4.9B | 6.2B | 7.0B | 7.7B | 8.0B | 8.1B |
| Gross profit margin, % | 74.6% | 76.4% | 71.6% | 73.7% | 73.0% | 68.8% | 66.0% | |
| Operating expense total | 2.5B | 3.0B | 2.8B | 3.6B | 3.9B | 4.4B | 5.2B | 5.7B |
| Depreciation and amortization | 236.3M | 477.1M | 287.1M | 339.5M | 431.4M | 431.3M | 552.8M | 581.9M |
| EBITDA | 1.3B | 2.0B | 2.2B | 2.6B | 3.1B | 3.3B | 2.9B | 2.5B |
| EBITDA margin, % | 30.2% | 33.8% | 30.6% | 32.2% | 31.2% | 25.3% | 20.2% | |
| EBIT | 1.1B | 1.5B | 1.9B | 2.3B | 2.6B | 2.5B | 2.4B | 1.9B |
| EBIT margin, % | 23.4% | 29.5% | 26.7% | 27.7% | 24.1% | 21.0% | 15.3% | |
| Interest income | 11.9M | 11.2M | 18.0M | 75.0M | 19.8M | 7.7M | 6.3M | 7.4M |
| Interest expense | 203.3M | 146.5M | 115.4M | 93.0M | 137.5M | 205.1M | 180.2M | 162.3M |
| Pre tax profit | 883.9M | 1.4B | 2.1B | 2.8B | 2.5B | 2.3B | 2.9B | 1.5B |
| Income tax expense | 147.5M | 230.5M | 292.4M | 380.8M | 418.6M | 448.8M | 386.3M | 249.8M |
| Net Income | 736.4M | 1.1B | 1.8B | 2.4B | 2.1B | 1.9B | 2.5B | 1.2B |